Treatment Use of the CliniMACS® CD34 Reagent System to Prepare Cells for an Unlabeled Indication Using an HLA-Compatible Related or Unrelated Donor for Allogenic Transplant
Study ID: STU 092014-037
Summary
This is not considered research. We are requesting iRB approval forfor use of CliniMaCS CD34 Reagent System to obtain CD34+ cell-enriched population for hematopoietic reconstitution following a myeloblative preparative regimen without the need for additonal graft versus host disease (GVHD) prophylaxis.
To process hematopoietic progenitor cells collected by apheresis (HPC, apheresis) from an related or unrelated donor to obtain CD34 enriched population for hematopoietic reconstitution following a myeloblative preparative regimen without the need for additional graft versus host disease (GVHD) prophylaxis.
